Seeking Alpha

  Northwest Biotherapeutics, Inc. - NASDAQ

10/22/2014, 5:50 AM ET
  • Puma Trader | Send Message 15 Jul

    Delmar Pharmaceutical's is trading at 1/10th the valuation of $NWBO with and $DMPI has 100x better chance of getting FDA approval.
    Reply (4)
  • View all 4 replies
    • Puma Trader | Send Message 16 Jul
      : Lack of exposure. The volume in their stock is a lot less than $NWBO. If $DMPI has a million shares traded per day stock would be at $2.50.
    • Puma Trader | Send Message 16 Jul
      : I talked to an oncologist in front of the $DMPI poster at ASCO in Chicago this year. He said $DMPI has an exciting drug.
      NWBO vs. ETF Alternatives
      Company Description
      Northwest Biotherapeutics Inc is a development stage biotechnology company engaged in the development of immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States